These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 17889375

  • 1. Decreased suppression of immune stimulatory CpG motifs in plant DNA.
    Wang Y, Zhou J, Liu B.
    Immunol Lett; 2007 Dec 15; 114(2):73-80. PubMed ID: 17889375
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides.
    Mannon RB, Nataraj C, Pisetsky DS.
    Cell Immunol; 2000 Apr 10; 201(1):14-21. PubMed ID: 10805969
    [Abstract] [Full Text] [Related]

  • 3. CpG motifs for optimization of DNA vaccines.
    Davis HL.
    Dev Biol (Basel); 2000 Apr 10; 104():165-9. PubMed ID: 11713816
    [Abstract] [Full Text] [Related]

  • 4. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
    Chaung HC.
    Int Immunopharmacol; 2006 Oct 10; 6(10):1586-96. PubMed ID: 16919831
    [Abstract] [Full Text] [Related]

  • 5. Mitogenicity of DNA from different organisms for murine B cells.
    Sun S, Beard C, Jaenisch R, Jones P, Sprent J.
    J Immunol; 1997 Oct 01; 159(7):3119-25. PubMed ID: 9317108
    [Abstract] [Full Text] [Related]

  • 6. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
    Yoshinaga T, Yasuda K, Ogawa Y, Nishikawa M, Takakura Y.
    Immunology; 2007 Mar 01; 120(3):295-302. PubMed ID: 17199803
    [Abstract] [Full Text] [Related]

  • 7. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA.
    Lee KW, Jung J, Lee Y, Kim TY, Choi SY, Park J, Kim DS, Kwon HJ.
    Mol Immunol; 2006 May 01; 43(13):2107-18. PubMed ID: 16442622
    [Abstract] [Full Text] [Related]

  • 8. Recent advances in immunostimulatory CpG oligonucleotides.
    Rothenfusser S, Tuma E, Wagner M, Endres S, Hartmann G.
    Curr Opin Mol Ther; 2003 Apr 01; 5(2):98-106. PubMed ID: 12772497
    [Abstract] [Full Text] [Related]

  • 9. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R, Roberts TL, Stacey KJ, Lenert P.
    Eur J Immunol; 2006 Jul 01; 36(7):1951-62. PubMed ID: 16791898
    [Abstract] [Full Text] [Related]

  • 10. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.
    Yamamoto S, Yamamoto T, Nojima Y, Umemori K, Phalen S, McMurray DN, Kuramoto E, Iho S, Takauji R, Sato Y, Yamada T, Ohara N, Matsumoto S, Goto Y, Matsuo K, Tokunaga T.
    Jpn J Infect Dis; 2002 Apr 01; 55(2):37-44. PubMed ID: 12082305
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant properties of CpG oligonucleotides in primates.
    Verthelyi D.
    Methods Mol Med; 2006 Apr 01; 127():139-58. PubMed ID: 16988453
    [Abstract] [Full Text] [Related]

  • 12. Bacterial DNA activates human neutrophils by a CpG-independent pathway.
    Trevani AS, Chorny A, Salamone G, Vermeulen M, Gamberale R, Schettini J, Raiden S, Geffner J.
    Eur J Immunol; 2003 Nov 01; 33(11):3164-74. PubMed ID: 14579285
    [Abstract] [Full Text] [Related]

  • 13. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
    Bauer S, Kirschning CJ, Häcker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB.
    Proc Natl Acad Sci U S A; 2001 Jul 31; 98(16):9237-42. PubMed ID: 11470918
    [Abstract] [Full Text] [Related]

  • 14. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
    Wilson HL, Dar A, Napper SK, Marianela Lopez A, Babiuk LA, Mutwiri GK.
    Int Rev Immunol; 2006 Jul 31; 25(3-4):183-213. PubMed ID: 16818371
    [Abstract] [Full Text] [Related]

  • 15. CpG motifs in bacterial DNA trigger direct B-cell activation.
    Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM.
    Nature; 1995 Apr 06; 374(6522):546-9. PubMed ID: 7700380
    [Abstract] [Full Text] [Related]

  • 16. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages.
    Shoda LK, Kegerreis KA, Suarez CE, Mwangi W, Knowles DP, Brown WC.
    J Leukoc Biol; 2001 Jul 06; 70(1):103-12. PubMed ID: 11435492
    [Abstract] [Full Text] [Related]

  • 17. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR, Zhu F, Li Y, Bhagat L, Cong Y, Kandimalla ER, Agrawal S.
    Nucleic Acids Res; 2006 Jul 06; 34(11):3231-8. PubMed ID: 16798912
    [Abstract] [Full Text] [Related]

  • 18. Activation of toll-like receptor 9 by DNA from different bacterial species.
    Dalpke A, Frank J, Peter M, Heeg K.
    Infect Immun; 2006 Feb 06; 74(2):940-6. PubMed ID: 16428738
    [Abstract] [Full Text] [Related]

  • 19. Immunostimulatory DNA as a vaccine adjuvant.
    Higgins D, Marshall JD, Traquina P, Van Nest G, Livingston BD.
    Expert Rev Vaccines; 2007 Oct 06; 6(5):747-59. PubMed ID: 17931155
    [Abstract] [Full Text] [Related]

  • 20. The immunophysiological impact of bacterial CpG DNA on the gut.
    Watson JL, McKay DM.
    Clin Chim Acta; 2006 Feb 06; 364(1-2):1-11. PubMed ID: 16153626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.